Virtus Investment Advisers’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-19
Closed -$2.75K 577
2024
Q4
$2.75K Sell
19
-1,000
-98% -$155K ﹤0.01% 359
2024
Q3
$165K Sell
1,019
-360
-26% -$57.4K 0.13% 216
2024
Q2
$202K Sell
1,379
-1,335
-49% -$199K 0.17% 180
2024
Q1
$429K Buy
2,714
+2,146
+378% +$342K 0.31% 101
2023
Q4
$89K Hold
568
0.07% 247
2023
Q3
$88.5K Sell
568
-66
-10% -$10.9K 0.06% 225
2023
Q2
$105K Hold
634
0.07% 239
2023
Q1
$98.3K Sell
634
-542
-46% -$87.5K 0.07% 248
2022
Q4
$208K Hold
1,176
0.14% 189
2022
Q3
$192K Buy
+1,176
New +$199K 0.09% 205
2018
Q1
Sell
-11,288
Closed -$1.58M 237
2017
Q4
$1.58M Sell
11,288
-728
-6% -$101K 0.17% 165
2017
Q3
$1.56M Sell
12,016
-1,183
-9% -$157K 0.16% 172
2017
Q2
$1.75M Sell
13,199
-2,557
-16% -$326K 0.17% 168
2017
Q1
$1.96M Buy
+15,756
New +$1.88M 0.17% 168
2016
Q4
Sell
-91,209
Closed -$10.8M 502
2016
Q3
$10.8M Buy
+91,209
New +$11.1M 0.69% 28

Other funds holding JNJ

Virtus Investment Advisers's JNJ Position: Q1 2025 in Review

Virtus Investment Advisers sold out of Johnson & Johnson (JNJ) in Q1 2025, closing a stake of 19 shares — an estimated $2.75K sold.

Virtus Investment Advisers first reported a position in JNJ in Q3 2016 and held it in 15 quarters. The position peaked at $10.8M in Q3 2016. 4,147 funds tracked by Wall St. Rank hold JNJ as of Q1 2025.

  • Virtus Investment Advisers reported no remaining Johnson & Johnson position as of Q1 2025 after selling out during the quarter.
  • Virtus Investment Advisers sold 19 Johnson & Johnson shares in Q1 2025, an estimated $2.75K.
  • Virtus Investment Advisers first reported a position in Johnson & Johnson in Q3 2016 and held it in 15 quarters.
  • Virtus Investment Advisers's Johnson & Johnson position peaked at $10.8M in Q3 2016.
  • 4,147 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2025.

Based on Virtus Investment Advisers's 13F filing for Q1 2025, filed 15 May 2025.